Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature ...
Nov 30, 2021
0
55
A new study led by City, University of London suggests that peer-befriending when stroke patients with aphasia are discharged from hospital and active care is withdrawn may help reduce depressive symptoms.
Mar 29, 2021
0
70
A new study by led by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine finds that exercising your brain with "neurobics" before surgery can help prevent post-surgery ...
Nov 11, 2020
0
93
Severe mental illness diagnoses are missed by clinicians in more than one quarter of cases when people are hospitalised for other conditions, finds a new study led by UCL researchers.
Sep 17, 2020
0
166
A team of researchers affiliated with multiple institutions in Europe has found a connection between patients who show more DNA methylation at some genome sites and a higher likelihood of failing to respond to metformin. ...
The famous, but bizarre, 'rubber hand illusion' could help people who suffer from obsessive compulsive disorder overcome their condition without the often unbearable stress of exposure therapy, suggests new research.
Jan 9, 2020
0
330
Statins could be used to treat older patients admitted to hospital with a severe type of pneumonia, researchers at the University of Birmingham have found.
Sep 13, 2019
0
280
Researchers from Osaka University find a new way to distinguish individuals with early pancreatic cancer from healthy controls, representing a promising new metric in cancer diagnosis
Sep 2, 2019
0
155
Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal ...
Apr 29, 2019
0
121
Australian researchers have identified epigenetic 'signatures' that could help clinicians tell the difference between highly aggressive and more benign forms of triple-negative breast cancer.
Feb 2, 2015
0
26
